Posted on March 23, 2015 by Gray Connections
Post by #LCSM Moderator Dr. H. Jack West: Earlier this month, the FDA made quick work of the application that Bristol-Myers-Squibb had just completed for Opdivo (nivolumab) for patients with squamous cell NSCLC that has previously been treated with standard chemotherapy. This was a very rapid decision, which highlighted the improvement in median overall survival from 6 to 9.2 months. So where are we now? What are the implications of the approval, both in terms of future approvals and the current treatment options for patients? Will Opdivo be the default best treatment… Read More
Posted on March 18, 2015 by Gray Connections
On March 19th, 2015, starting around 10AM PT, UC Davis will be using #LCSM and #UCDVATS hashtags to live tweet the experience of a patient undergoing minimally invasive surgery for lung cancer. David Tom Cooke, MD, FACS, (@DavidCookeMD) , head of University of California at Davis Thoracic Surgery and #LCSM Co-Founder, explains why: “Is there a cure for lung cancer?” I hear this question often. Many of you know that lung cancer has a five-year survival rate of around 15%. One reason this rate is so low is because lung cancer patients are rarely… Read More
Posted on March 9, 2015 by Gray Connections
Cancer patients and their caregivers come to patient communities (whether online or in real life) for reasons such as seeking support, finding hope, and learning about their disease. Eventually some become a source of support, hope and information through their activities. These patients and caregivers sometimes express a desire to reach out to other patients and caregivers, to give back in appreciation for the help they received with their cancer experience. This may take the form of blogging, participating in fundraisers, volunteering for advocacy projects, or other activities. But sometimes those who… Read More
#LCSM 
You must be logged in to post a comment.